1. Home
  2. PGEN vs HYI Comparison

PGEN vs HYI Comparison

Compare PGEN & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • HYI
  • Stock Information
  • Founded
  • PGEN 1998
  • HYI 2010
  • Country
  • PGEN United States
  • HYI United States
  • Employees
  • PGEN N/A
  • HYI N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • HYI Investment Managers
  • Sector
  • PGEN Health Care
  • HYI Finance
  • Exchange
  • PGEN Nasdaq
  • HYI Nasdaq
  • Market Cap
  • PGEN 292.6M
  • HYI 279.2M
  • IPO Year
  • PGEN N/A
  • HYI N/A
  • Fundamental
  • Price
  • PGEN $0.78
  • HYI $12.22
  • Analyst Decision
  • PGEN Buy
  • HYI
  • Analyst Count
  • PGEN 5
  • HYI 0
  • Target Price
  • PGEN $7.00
  • HYI N/A
  • AVG Volume (30 Days)
  • PGEN 905.3K
  • HYI 50.6K
  • Earning Date
  • PGEN 11-14-2024
  • HYI 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • HYI 9.59%
  • EPS Growth
  • PGEN N/A
  • HYI N/A
  • EPS
  • PGEN N/A
  • HYI N/A
  • Revenue
  • PGEN $3,963,000.00
  • HYI N/A
  • Revenue This Year
  • PGEN N/A
  • HYI N/A
  • Revenue Next Year
  • PGEN $426.76
  • HYI N/A
  • P/E Ratio
  • PGEN N/A
  • HYI N/A
  • Revenue Growth
  • PGEN N/A
  • HYI N/A
  • 52 Week Low
  • PGEN $0.76
  • HYI $10.99
  • 52 Week High
  • PGEN $1.93
  • HYI $12.24
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 39.38
  • HYI 55.65
  • Support Level
  • PGEN $0.76
  • HYI $12.00
  • Resistance Level
  • PGEN $0.97
  • HYI $12.21
  • Average True Range (ATR)
  • PGEN 0.07
  • HYI 0.13
  • MACD
  • PGEN -0.01
  • HYI 0.02
  • Stochastic Oscillator
  • PGEN 7.90
  • HYI 100.00

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About HYI Western Asset High Yield Defined Opportunity Fund Inc.

Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.

Share on Social Networks: